140 related articles for article (PubMed ID: 10835067)
1. Metabolic aspects of myocardial disease and a role for L-carnitine in the treatment of childhood cardiomyopathy.
Helton E; Darragh R; Francis P; Fricker FJ; Jue K; Koch G; Mair D; Pierpont ME; Prochazka JV; Linn LS; Winter SC
Pediatrics; 2000 Jun; 105(6):1260-70. PubMed ID: 10835067
[TBL] [Abstract][Full Text] [Related]
2. The role of L-carnitine in pediatric cardiomyopathy.
Winter S; Jue K; Prochazka J; Francis P; Hamilton W; Linn L; Helton E
J Child Neurol; 1995 Nov; 10 Suppl 2():S45-51. PubMed ID: 8576569
[TBL] [Abstract][Full Text] [Related]
3. A retrospective epidemiological and etiological study of metabolic disorders in children with cardiomyopathies.
Wang SM; Hou JW; Lin JL
Acta Paediatr Taiwan; 2006; 47(2):83-7. PubMed ID: 16927633
[TBL] [Abstract][Full Text] [Related]
4. Clinical spectrum, morbidity, and mortality in 113 pediatric patients with mitochondrial disease.
Scaglia F; Towbin JA; Craigen WJ; Belmont JW; Smith EO; Neish SR; Ware SM; Hunter JV; Fernbach SD; Vladutiu GD; Wong LJ; Vogel H
Pediatrics; 2004 Oct; 114(4):925-31. PubMed ID: 15466086
[TBL] [Abstract][Full Text] [Related]
5. NTP Toxicology and Carcinogenesis Studies of Coumarin (CAS No. 91-64-5) in F344/N Rats and B6C3F1 Mice (Gavage Studies).
National Toxicology Program
Natl Toxicol Program Tech Rep Ser; 1993 Sep; 422():1-340. PubMed ID: 12616289
[TBL] [Abstract][Full Text] [Related]
6. The effect of gender on mortality or appropriate shock in patients with nonischemic cardiomyopathy who have implantable cardioverter-defibrillators.
Chen HA; Hsia HH; Vagelos R; Fowler M; Wang P; Al-Ahmad A
Pacing Clin Electrophysiol; 2007 Mar; 30(3):390-4. PubMed ID: 17367359
[TBL] [Abstract][Full Text] [Related]
7. Patients with recently diagnosed nonischemic cardiomyopathy benefit from implantable cardioverter-defibrillators.
Kadish A; Schaechter A; Subacius H; Thattassery E; Sanders W; Anderson KP; Dyer A; Goldberger J; Levine J
J Am Coll Cardiol; 2006 Jun; 47(12):2477-82. PubMed ID: 16781376
[TBL] [Abstract][Full Text] [Related]
8. NTP technical report on the toxicity studies of Dibutyl Phthalate (CAS No. 84-74-2) Administered in Feed to F344/N Rats and B6C3F1 Mice.
Marsman D
Toxic Rep Ser; 1995 Apr; 30():1-G5. PubMed ID: 12209194
[TBL] [Abstract][Full Text] [Related]
9. NTP Toxicology and Carcinogenesis Studies of Diethylphthalate (CAS No. 84-66-2) in F344/N Rats and B6C3F1 Mice (Dermal Studies) with Dermal Initiation/ Promotion Study of Diethylphthalate and Dimethylphthalate (CAS No. 131-11-3) in Male Swiss (CD-1(R)) Mice.
National Toxicology Program
Natl Toxicol Program Tech Rep Ser; 1995 May; 429():1-286. PubMed ID: 12616302
[TBL] [Abstract][Full Text] [Related]
10. [Clinical presentation and therapeutic outcomes of carnitine deficiency-induced cardiomyopathy].
Fu LJ; Chen SB; Han LS; Guo Y; Zhao PJ; Zhu M; Li F; Huang MR
Zhonghua Er Ke Za Zhi; 2012 Dec; 50(12):929-34. PubMed ID: 23324152
[TBL] [Abstract][Full Text] [Related]
11. Factors associated with establishing a causal diagnosis for children with cardiomyopathy.
Cox GF; Sleeper LA; Lowe AM; Towbin JA; Colan SD; Orav EJ; Lurie PR; Messere JE; Wilkinson JD; Lipshultz SE
Pediatrics; 2006 Oct; 118(4):1519-31. PubMed ID: 17015543
[TBL] [Abstract][Full Text] [Related]
12. NTP Toxicology and Carcinogenesis Studies of Oxazepam (CAS No. 604-75-1) in Swiss-Webster and B6C3F1 Mice (Feed Studies).
National Toxicology Program
Natl Toxicol Program Tech Rep Ser; 1993 Aug; 443():1-321. PubMed ID: 12595920
[TBL] [Abstract][Full Text] [Related]
13. NTP Toxicology and Carcinogenesis Studies of o-Benzyl-p-Chlorophenol (CAS No. 120-32-1) in F344/N Rats and B6C3F1 Mice (Gavage Studies).
National Toxicology Program
Natl Toxicol Program Tech Rep Ser; 1994 Jan; 424():1-304. PubMed ID: 12616287
[TBL] [Abstract][Full Text] [Related]
14. Detecting life-threatening lactic acidosis related to nucleoside-analog treatment of human immunodeficiency virus-infected patients, and treatment with L-carnitine.
Claessens YE; Cariou A; Monchi M; Soufir L; Azoulay E; Rouges P; Goldgran-Toledano D; Branche F; Dhainaut JF
Crit Care Med; 2003 Apr; 31(4):1042-7. PubMed ID: 12682470
[TBL] [Abstract][Full Text] [Related]
15. NTP Toxicology and Carcinogenesis Studies of Scopolamine Hydrobromide Trihydrate (CAS No. 6533-68-2) in F344 Rats and B6C3F1 Mice (Gavage Studies).
National Toxicology Program
Natl Toxicol Program Tech Rep Ser; 1997 Mar; 445():1-277. PubMed ID: 12594530
[TBL] [Abstract][Full Text] [Related]
16. NTP Toxicology and Carcinogenesis Studies of 1,2-Dihydro-2,2,4-Trimethylquinoline (CAS No. 147-47-7) in F344/N Rats and B6C3F1 Mice (Dermal Studies) and the Dermal Initiation/Promotion Study in Female Sencar Mice.
National Toxicology Program
Natl Toxicol Program Tech Rep Ser; 1997 Feb; 456():1-312. PubMed ID: 12587020
[TBL] [Abstract][Full Text] [Related]
17. Use of ACE inhibitors or angiotensin receptor blockers and survival in patients on peritoneal dialysis.
Fang W; Oreopoulos DG; Bargman JM
Nephrol Dial Transplant; 2008 Nov; 23(11):3704-10. PubMed ID: 18567695
[TBL] [Abstract][Full Text] [Related]
18. Improved outcomes of pediatric dilated cardiomyopathy with utilization of heart transplantation.
Tsirka AE; Trinkaus K; Chen SC; Lipshultz SE; Towbin JA; Colan SD; Exil V; Strauss AW; Canter CE
J Am Coll Cardiol; 2004 Jul; 44(2):391-7. PubMed ID: 15261937
[TBL] [Abstract][Full Text] [Related]
19. Renal involvement in systemic amyloidosis: an Italian collaborative study on survival and renal outcome.
Bergesio F; Ciciani AM; Manganaro M; Palladini G; Santostefano M; Brugnano R; Di Palma AM; Gallo M; Rosati A; Tosi PL; Salvadori M;
Nephrol Dial Transplant; 2008 Mar; 23(3):941-51. PubMed ID: 17951308
[TBL] [Abstract][Full Text] [Related]
20. L-carnitine administration in coronary artery disease and cardiomyopathy.
Singh RB; Aslam M
J Assoc Physicians India; 1998 Sep; 46(9):801-5. PubMed ID: 11229253
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
